Research study Program year 2024 Source: CMS Open Payments

2102-Hem-101

Research payments

$180,307

11 payments

Through program year 2024, $180,307 in research payments was reported against 2102-Hem-101, across 11 payments, paid by Novo Nordisk Inc.

Paid by: Novo Nordisk Inc
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2024	Research	$180,307	11

Breakdown

Who paid Research payments · program year 2024

Novo Nordisk Inc $180,307 11 payments

Who received the money Research payments · program year 2024

Regents Of The University Of California Organisation paid for research $60,694 2 payments
University of Maryland Baltimore Organisation paid for research $24,665 1 payment
Weill Cornell Medical College Department Of Neurology Organisation paid for research $23,840 1 payment
Northwestern University Center Of Research Organisation paid for research $21,637 1 payment
Oregon Health And Science Univ Organisation paid for research $16,184 1 payment
The Trustees Of Columbia University In The City Of New York Organisation paid for research $9,834 1 payment
New York Medical College Organisation paid for research $9,173 1 payment
The University Of Texas Southwestern Medical Center Organisation paid for research $7,162 1 payment
Sarah Cannon Research Institute Organisation paid for research $5,428 1 payment
Duke University Medical Center Organisation paid for research $1,690 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.